Re: Skeletal fracture associated with androgen suppression induced osteoporosis: the clinical incidence and risk factors for patients with prostate cancer.
Carlos
C
Miró
Ottavio
O
De Cobelli
Roberto
R
Orecchia
Gemma
G
Sancho
Humberto
H
Villavicencio
Jordi
J
Craven-Bartle
D000368:Aged; D000726:Androgen Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary; D003937:Diagnosis, Differential; D005598:Fractures, Spontaneous / Q000209:etiology*; D006801:Humans; D007085:Ilium / Q000293:injuries / Q000528:radiation effects; D008297:Male; D009919:Orchiectomy; D010024:Osteoporosis / Q000209:etiology*; D010025:Osteoradionecrosis / Q000209:etiology; D011471:Prostatic Neoplasms / Q000628:therapy*; D012307:Risk Factors
D000726:Androgen Antagonists